Identification of neurogenetic pathways of risk for psychopathology

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 148, Issue 2, 2008, Pages 147-153

  Fisher, Patrick M ^a   Muñoz, Karen E ^a   Hariri, Ahmad R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Neurogenetic pathways; Psychopathology

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

BEHAVIOR; BRAIN FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; MENTAL DISEASE; NERVE CONDUCTION; NEUROIMAGING; PRIORITY JOURNAL; REVIEW;

BRAIN; CATECHOL O-METHYLTRANSFERASE; DIAGNOSTIC IMAGING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MONOAMINE OXIDASE; PSYCHOPATHOLOGY; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 43949138935     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30173     Document Type: Review

References (48)

1. Brown SM, Hariri AR. 2006. Neuroimaging studies of serotonin gene polymorphisms: Exploring the interplay of genes, brain, and behavior. Cogn Affect Behav Neurosci 6:44-52.
2. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR. 2005. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 10:805.
3. Canli T, Congdon E, Gutknecht L, Constable RT, Lesch KP. 2005a. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm 112:1479-1485.
4. Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP. 2005b. Beyond affect: A role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci USA 102:12224-12229.
5. Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, Herrmann MJ, Constable RT, Lesch KP. 2006. Neural correlates of epigenesis. Proc Natl Acad Sci USA 103:16033-16038.
6. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
7. David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. 2005. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25:2586-2590.
8. Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J. 2006. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9:349-355.
9. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. 2006. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 63:1396-1406.
10. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
11. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW. 2004. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 9:908-915.
12. Fisher PM, Meltzer CC, Ziolko SK, Price JC, Hariri AR. 2006. Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci 9:1362-1363.
13. Forbes EE, Brown SM, Kunak M, Ferrell RE, Manuck SB, Hariri AR. 2007. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry.
14. Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Langstrom B, Oreland L, Fredrikson M. 2004. Serotonin transporter polymorphism linked to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362:1-4.
15. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. 2001. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 115:358-364.
16. Glatt CE, Freimer NB. 2002. Association analysis of candidate genes for neuropsychiatric disease: The perpetual campaign. Trends Genet 18:307-312.
17. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TFIII, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 101:8174-8179.
18. Goldman-Rakic PS. 1996. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93:13473-13480.
19. Hariri AR, Holmes A. 2006. Genetics of emotional regulation: The role of the serotonin transporter in neural function. Trends Cogn Sci 10:182-191.
20. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403.
21. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR. 2005. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62:146-152.
22. Hariri AR, Drabant EM, Weinberger DR. 2006. Imaging genetics: Perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 59:888-897.
23. Heinz A, Smolka M, Braus D. 2004. Amygdala activation, prefrontal metabolism and the serotonin transporter. Biol Psychiatry 55:43.
24. Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, Mann K, Schumann G, Buchel C, Hariri AR, Weinberger DR. 2006. Serotonin transporter genotype (5-HTTLPR): Effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 61:1011-1014.
25. Hesse S, Barthel H, Murai T, Muller U, Muller D, Seese A, Kluge R, Sabri O. 2003. Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging 30:427-430.
26. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. 2005. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry 62:529-535.
27. Lee M, Bailer UF, Frank GK, Henry SE, Meltzer CC, Price JC, Mathis CA, Putnam KT, Ferrell RE, Hariri AR, Kaye WH. 2005. Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. Mol Psychiatry 10:715-716.
28. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
29. Luellen BA, Bianco LE, Schneider LM, Andrews AM. 2006. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav 6:482-490.
30. Maier SF, Watkins LR. 2005. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 29:829-841.
31. Malhotra AK, Goldman D. 1999. Benefits and pitfalls encountered in psychiatric genetic association studies. Biol Psychiatry 45:544-550.
32. Mattick JS. 2004. RNA regulation: A new genetics? Nat Rev Genet 5:316.
33. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri AR, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. 2006. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 103:6269-6274.
34. Munafo MR, Clark T, Flint J. 2005. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry 10:415-419.
35. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ. 2006. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163:48-51.
36. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834.
37. Plomin R, Owen MJ, McGuffin P. 1994. The genetic basis of complex human behaviors. Science 264:1733-1739.
38. Ren-Patterson RF, Cochran LW, Holmes A, Lesch KP, Lu B, Murphy DL. 2006. Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol 26:753-778.
39. Richards EJ. 2006. Inherited epigenetic variation - Revisiting soft inheritance. Nat Rev Genet 7:395.
40. Schinka JA, Busch RM, Robichaux-Keene N. 2004. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9:197-202.
41. Sen S, Burmeister M, Ghosh D. 2004. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet Part B Neuropsychiatr Genet 127B:85-89.
42. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18: 2697-2708.
43. Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F, Hirano M, Shinohara M, Kagami M, Okubo Y, Nankai M, Kanba S. 2003. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48:184-188.
44. Szyf M, Weaver I, Meaney M. 2007. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 24:9-19.
45. Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH, Axelson D, Whalen PJ, Casey BJ. 2001. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58:1057-1063.
46. Tsankova N, Renthal W, Kumar A, Nestler EJ. 2007. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355-367.
47. van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB. 2000. Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. Neurobiol Aging 21:497-501.
48. Weinshilboum RM, Otterness DM, Szumlanski CL. 1999. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39:19-52.